Genmab creates antibodies for the treatment of cancer. We use our in-depth knowledge of antibody biology to generate and select the best possible antibody products. Genmab continues to innovate the process of antibody discovery and the development of next generation antibody platforms. This will provide a steady stream of future antibody product candidates. Click here to read more about our proprietary antibody technologies.